CN116870102A - Traditional Chinese medicine composition for reducing blood sugar and application thereof - Google Patents
Traditional Chinese medicine composition for reducing blood sugar and application thereof Download PDFInfo
- Publication number
- CN116870102A CN116870102A CN202310933673.1A CN202310933673A CN116870102A CN 116870102 A CN116870102 A CN 116870102A CN 202310933673 A CN202310933673 A CN 202310933673A CN 116870102 A CN116870102 A CN 116870102A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- aspongopus
- hypoglycemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 239000008280 blood Substances 0.000 title claims abstract description 68
- 210000004369 blood Anatomy 0.000 title claims abstract description 68
- 230000001603 reducing effect Effects 0.000 title claims abstract description 53
- 241000270708 Testudinidae Species 0.000 claims abstract description 62
- 241000660877 Coridius Species 0.000 claims abstract description 58
- 235000008434 ginseng Nutrition 0.000 claims abstract description 32
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 31
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 31
- 210000000582 semen Anatomy 0.000 claims abstract description 31
- 240000000249 Morus alba Species 0.000 claims abstract description 25
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 25
- 240000008042 Zea mays Species 0.000 claims abstract description 25
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 24
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 24
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 24
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 24
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 24
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 24
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 24
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 24
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 24
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 24
- 235000007244 Zea mays Nutrition 0.000 claims abstract description 24
- 229940089639 cornsilk Drugs 0.000 claims abstract description 24
- 239000001231 zea mays silk Substances 0.000 claims abstract description 24
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 19
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 19
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 19
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 19
- 238000011282 treatment Methods 0.000 claims abstract description 12
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 46
- 241000208340 Araliaceae Species 0.000 claims description 31
- 239000006187 pill Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 235000012907 honey Nutrition 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- 240000001899 Murraya exotica Species 0.000 claims description 9
- 235000008766 Murraya exotica Nutrition 0.000 claims description 9
- 235000009696 Murraya paniculata Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 238000007873 sieving Methods 0.000 claims description 9
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004142 Trypsin Human genes 0.000 claims description 4
- 108090000631 Trypsin Proteins 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000012588 trypsin Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 15
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000008093 supporting effect Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 235000008734 Bergera koenigii Nutrition 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 240000002393 Murraya koenigii Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000022329 Protein metabolism disease Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- XFOHHIYSRDUSCX-UHFFFAOYSA-M sodium;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione Chemical compound [Na+].C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)[N-]C1=O XFOHHIYSRDUSCX-UHFFFAOYSA-M 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The application relates to a traditional Chinese medicine composition for reducing blood sugar and application thereof, and relates to the technical field of traditional Chinese medicines, wherein the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight: 40-60 parts of tortoise plastron, 40-60 parts of medlar, 30-40 parts of aspongopus, 15-25 parts of semen astragali complanati, 5-15 parts of mulberry, 5-15 parts of ginseng, 5-20 parts of hawthorn and 5-20 parts of corn silk. The application provides a blood sugar-reducing traditional Chinese medicine composition containing aspongopus, and the components of the traditional Chinese medicine composition are mutually cooperated and act together to ensure that the traditional Chinese medicine composition has remarkable blood sugar-reducing effect, can effectively treat and/or prevent diabetes mellitus, provides a new path for the treatment of diabetics, and has practical application value.
Description
Technical Field
The application relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for reducing blood sugar and application thereof.
Background
Diabetes is a metabolic disease characterized by hyperglycemia due to relative insulin deficiency or insulin resistance. The diabetes patients have fat and protein metabolism disorder, and clinically can show the symptoms of diuresis, polydipsia, emaciation and the like, and the long-term hyperglycemia is easy to cause acute complications such as ketoacidosis and the like or chronic complications such as blood vessels, nerves and the like. Among them, type ii diabetes is the most common type of diabetes, and its occurrence and development are related to various factors such as insulin resistance, obesity, or impaired beta cell function.
The existing treatment of diabetes mainly controls blood sugar and reduces complications. The hypoglycemic medicine mainly comprises oral western medicines hypoglycemic medicine and injection insulin analogues, but the sustained administration is required, and the side effect of the medicine is obvious. Therefore, in recent years, the adoption of traditional Chinese medicine treatment has become an important choice for treating diabetes, but at present, a traditional Chinese medicine formula with ideal blood glucose reducing effect is still lacking.
Disclosure of Invention
In order to solve the problems, the application provides a traditional Chinese medicine composition for reducing blood sugar and application thereof, and the traditional Chinese medicine composition has remarkable blood sugar reducing effect and can effectively treat and/or prevent diabetes.
In a first aspect, the application provides a traditional Chinese medicine composition for reducing blood sugar, which comprises the following components in parts by weight:
40-60 parts of tortoise plastron, 40-60 parts of medlar, 30-40 parts of aspongopus, 15-25 parts of semen astragali complanati, 5-15 parts of mulberry, 5-15 parts of ginseng, 5-20 parts of hawthorn and 5-20 parts of corn silk.
Further, the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight:
45-55 parts of tortoise plastron, 45-55 parts of medlar, 35-40 parts of aspongopus, 20-25 parts of semen astragali complanati, 5-10 parts of mulberry, 5-10 parts of ginseng, 10-20 parts of hawthorn and 15-20 parts of corn silk.
Further, the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight:
50 parts of tortoise plastron, 50 parts of medlar, 37 parts of aspongopus, 22 parts of aspongopus, 20 parts of semen astragali complanati, 10 parts of mulberry, 10 parts of ginseng, 20 parts of hawthorn and 18 parts of corn silk.
In a second aspect, the application provides an application of the hypoglycemic Chinese medicinal composition in any one of the first aspect in preparing hypoglycemic products.
In a third aspect, the application provides a traditional Chinese medicine honeyed pill for reducing blood sugar, and the functional components of the traditional Chinese medicine honeyed pill for reducing blood sugar comprise the traditional Chinese medicine composition for reducing blood sugar in any one of the first aspect.
Further, the preparation method of the traditional Chinese medicine honeyed pill for reducing blood sugar comprises the following steps:
decalcification treatment is carried out on tortoise plastron, and enzymolysis is carried out to obtain tortoise plastron protein extract;
carrying out supercritical extraction on the aspongopus to obtain aspongopus extract;
extracting fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis with water to obtain mixed extract;
mixing and sieving the tortoise plastron protein extract, the aspongopus extract and the mixed extract, adding the mixture into honey, stirring, and preparing the traditional Chinese medicine honeyed pill for reducing blood sugar.
Further, the steps of decalcification treatment of tortoise plastron and enzymolysis to obtain tortoise plastron protein extract comprise the following steps:
crushing tortoise plastron, adding the crushed tortoise plastron into 0.5-1.0 mol/L ethylenediamine tetraacetic acid, and stirring for 1-3 hours to obtain a first reaction feed liquid;
adding 0.8-1.2 mol/L alkali liquor into the first reaction feed liquor, stirring for 4-7 hours, and then centrifugally filtering and washing to obtain decalcified tortoise plastron solids;
adding the decalcified tortoise plastron solid into water for cooking for 1-3 hours, cooling to room temperature, and adding trypsin with the enzyme amount of 2-3 ten thousand U for enzymolysis for 5-8 hours to obtain the tortoise plastron protein extract.
Further, the working parameters of the supercritical extraction include: the solvent is supercritical carbon dioxide fluid, the pressure is 40-50 Mpa, the temperature is 45-55 ℃ and the time is 1-2 hours.
Further, the step of extracting the wolfberry fruit, the murraya paniculata, the semen astragali complanati, the mulberry, the ginseng, the hawthorn and the corn silk with water to obtain a mixed extract comprises the following steps of:
pulverizing fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis, extracting with 5-8 times of water, concentrating under reduced pressure, and drying to obtain the mixed extract; wherein the extracted working parameters include: the temperature is 100-110 ℃, the time is 1-3 hours, and the times are 1-3 times.
Further, the weight ratio of the hypoglycemic Chinese medicinal composition to the honey is 1 (1-2).
Compared with the prior art, the technical scheme provided by the embodiment of the application has at least the following advantages:
the embodiment of the application provides a traditional Chinese medicine composition for reducing blood sugar, in particular to a traditional Chinese medicine composition for reducing blood sugar containing aspongopus, which takes tortoise plastron, medlar and aspongopus as monarch drugs and has the effects of nourishing yin, moistening lung, promoting qi circulation and removing deficiency of both yin; takes murraya paniculata and semen astragali Complanati as ministerial drugs, and has the effects of promoting blood circulation, removing blood stasis, tonifying kidney and supporting yang; and mulberry, ginseng, hawthorn and corn silk are matched as adjuvant drugs to promote the production of body fluid, moisten dryness, break qi, remove food retention, strengthen stomach and promote blood circulation. The medicines are combined together, and all the components are mutually cooperated, so that the medicine has remarkable blood sugar reducing effect, can effectively treat and/or prevent diabetes mellitus, provides a new path for treating diabetes mellitus patients (especially type II diabetes mellitus patients), and has practical application value.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions of the present application will be clearly and completely described in conjunction with the embodiments of the present application, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
Unless otherwise specifically indicated, the various raw materials, reagents, instruments, equipment and the like used in the present application are commercially available or may be prepared by existing methods.
In a first aspect, the application provides a traditional Chinese medicine composition for reducing blood sugar, which comprises the following components in parts by weight:
40-60 parts of tortoise plastron, 40-60 parts of medlar, 30-40 parts of aspongopus, 15-25 parts of semen astragali complanati, 5-15 parts of mulberry, 5-15 parts of ginseng, 5-20 parts of hawthorn and 5-20 parts of corn silk.
Tortoise plastron: is prepared from the tortoise shell and the abdominal shell, and has the effects of nourishing yin, suppressing yang, tonifying kidney, strengthening bone, nourishing blood, tonifying heart, and the like.
Wolfberry fruit: is a dried mature fruit of Lycium barbarum of Solanaceae, and has effects of replenishing kidney essence, moistening lung, and nourishing liver.
Aspongopus (L.) kuntze: is the body of Aspongopus of stinkbugaceae, and has effects of activating qi-flowing, relieving pain, warming kidney, and supporting yang.
Murraya paniculata: is prepared from dried leaves and twigs of Murraya koenigii and Murraya koenigii of Rutaceae, and has effects of activating qi-flowing, relieving pain, promoting blood circulation, removing blood stasis, etc.
Semen astragali Complanati: is a dry mature seed of astragalus membranaceus which is a leguminous plant, and has the effects of tonifying kidney, supporting yang, securing essence, reducing urination, nourishing liver, improving eyesight and the like.
Mulberry: is dry fruit ear of Morus alba Linne of Moraceae, and has effects of nourishing yin, replenishing blood, promoting salivation, and moistening dryness.
Ginseng: is prepared from dried root and rhizome of Panax ginseng of Araliaceae, and has effects of invigorating primordial qi, recovering pulse, relieving depletion, invigorating spleen, benefiting lung, promoting salivation, nourishing blood, tranquilizing mind, improving intelligence, etc.
Hawthorn fruit: is a dried and mature fruit of the hawthorn plant, and has the effects of invigorating stomach, promoting digestion, promoting qi circulation, removing blood stasis, resolving turbidity, reducing lipid and the like.
Corn silk: is prepared from the flower column and the column head of maize, which are the gramineous plants, and has the effects of inducing diuresis to alleviate edema, clearing liver-fire, promoting bile flow and the like.
The embodiment of the application provides a traditional Chinese medicine composition for reducing blood sugar, in particular to a traditional Chinese medicine composition for reducing blood sugar containing aspongopus, which takes tortoise plastron, medlar and aspongopus as monarch drugs and has the effects of nourishing yin, moistening lung, promoting qi circulation and removing deficiency of both yin; takes murraya paniculata and semen astragali Complanati as ministerial drugs, and has the effects of promoting blood circulation, removing blood stasis, tonifying kidney and supporting yang; and mulberry, ginseng, hawthorn and corn silk are matched as adjuvant drugs to promote the production of body fluid, moisten dryness, break qi, remove food retention, strengthen stomach and promote blood circulation. The medicines are combined together, and all the components are mutually cooperated, so that the medicine has remarkable blood sugar reducing effect, can effectively treat and/or prevent diabetes mellitus, provides a new path for treating diabetes mellitus patients (especially type II diabetes mellitus patients), and has practical application value.
In some embodiments, the tortoise plastron may be 40 parts, 41 parts, 42 parts, 43 parts, 44 parts, 45 parts, 46 parts, 47 parts, 48 parts, 49 parts, 50 parts, 51 parts, 52 parts, 53 parts, 54 parts, 55 parts, 56 parts, 57 parts, 58 parts, 59 parts, 60 parts, etc.
In some embodiments, the weight fraction of the wolfberry fruit may be 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, etc.
In some embodiments, the aspongopus may be 30 parts, 31 parts, 32 parts, 33 parts, 34 parts, 35 parts, 36 parts, 37 parts, 38 parts, 39 parts, 40 parts, etc.
In some embodiments, the parts by weight of murraya paniculata may be 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, etc.
In some embodiments, the weight parts of the semen astragali complanati may be 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, etc.
In some embodiments, the mulberry may be 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, etc.
In some embodiments, the ginseng may be 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, etc.
In some embodiments, the weight parts of the hawthorn can be 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, etc.
In some embodiments, the corn silk can be 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, etc.
Preferably, the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight:
45-55 parts of tortoise plastron, 45-55 parts of medlar, 35-40 parts of aspongopus, 20-25 parts of semen astragali complanati, 5-10 parts of mulberry, 5-10 parts of ginseng, 10-20 parts of hawthorn and 15-20 parts of corn silk.
More preferably, the hypoglycemic traditional Chinese medicine composition comprises the following components in parts by weight:
50 parts of tortoise plastron, 50 parts of medlar, 37 parts of aspongopus, 22 parts of aspongopus, 20 parts of semen astragali complanati, 10 parts of mulberry, 10 parts of ginseng, 20 parts of hawthorn and 18 parts of corn silk.
In some embodiments, the preparation method of the traditional Chinese medicine composition comprises the following steps:
decalcification treatment is carried out on tortoise plastron, and enzymolysis is carried out to obtain tortoise plastron protein extract;
carrying out supercritical extraction on the aspongopus to obtain aspongopus extract;
extracting fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis with water to obtain mixed extract;
mixing and sieving the tortoise plastron protein extract, the aspongopus extract and the mixed extract to obtain the traditional Chinese medicine composition.
The components of the hypoglycemic Chinese medicinal composition provided by the embodiment of the application can be directly commercially available products if the raw materials are not limited or described in particular.
In a second aspect, based on a general inventive concept, the present application provides a use of the hypoglycemic Chinese medicinal composition according to any one of the first aspect in preparing a hypoglycemic product.
The blood sugar-reducing traditional Chinese medicine composition containing aspongopus, provided by the embodiment of the application, has a remarkable blood sugar-reducing effect, can effectively treat and/or prevent diabetes, provides a new path for treating diabetes patients (especially type II diabetes patients), and has practical application value.
In a third aspect, the application provides a traditional Chinese medicine honeyed pill for reducing blood sugar, and the functional components of the traditional Chinese medicine honeyed pill for reducing blood sugar comprise the traditional Chinese medicine composition for reducing blood sugar in any one of the first aspect.
The embodiment of the application provides a traditional Chinese medicine honeyed pill for reducing blood sugar, which is an oral medicine, can improve the taste of the medicine, is easy to take, can better preserve the effective components of the Chinese herbal medicine, and achieves the optimal treatment effect.
As an implementation mode of the embodiment of the application, the preparation method of the traditional Chinese medicine honeyed pill for reducing blood sugar comprises the following steps:
decalcification treatment is carried out on tortoise plastron, and enzymolysis is carried out to obtain tortoise plastron protein extract;
carrying out supercritical extraction on the aspongopus to obtain aspongopus extract;
extracting fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis with water to obtain mixed extract;
mixing and sieving the tortoise plastron protein extract, the aspongopus extract and the mixed extract, adding the mixture into honey, stirring, and preparing the traditional Chinese medicine honeyed pill for reducing blood sugar.
The applicant researches find that the specific methods are adopted to extract tortoise plastron, aspongopus, medlar, murraya paniculata, semen astragali complanati, mulberry, ginseng, hawthorn and corn silk respectively, and then honey is added to prepare the honeyed pill, so that the blood sugar reducing effect of the medicament is better.
In some embodiments, the step of decalcifying tortoise plastron and then performing enzymolysis to obtain the tortoise plastron protein extract comprises the following steps:
crushing tortoise plastron, adding the crushed tortoise plastron into 0.5-1.0 mol/L ethylenediamine tetraacetic acid, and stirring for 1-3 hours to obtain a first reaction feed liquid;
adding 0.8-1.2 mol/L alkali liquor into the first reaction feed liquor, stirring for 4-7 hours, and then centrifugally filtering and washing to obtain decalcified tortoise plastron solids;
adding the decalcified tortoise plastron solid into water for cooking for 1-3 hours, cooling to room temperature, and adding trypsin with the enzyme amount of 2-3 ten thousand U for enzymolysis for 5-8 hours to obtain the tortoise plastron protein extract.
In some embodiments, the operating parameters of the supercritical extraction include: the solvent is supercritical carbon dioxide fluid, the pressure is 40-50 Mpa, the temperature is 45-55 ℃ and the time is 1-2 hours.
In some embodiments, the step of extracting the wolfberry fruit, the murraya paniculata, the semen astragali complanati, the mulberry, the ginseng, the hawthorn and the corn silk with water to obtain the mixed extract comprises the following steps:
pulverizing fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis, extracting with 5-8 times of water, concentrating under reduced pressure, and drying to obtain the mixed extract; wherein the extracted working parameters include: the temperature is 100-110 ℃, the time is 1-3 hours, and the times are 1-3 times.
In some specific embodiments, the process of preparing the honeyed pill by adding honey can be carried out according to the prior art, for example, the honey is weighed according to the weight ratio of the hypoglycemic Chinese medicinal composition to the honey of 1 (1-2), then the honey is heated and boiled for 4-6 minutes, and the honey pill is prepared by adding the honey into medicinal powder prepared by the Chinese medicinal composition, uniformly mixing and cooling. In some specific embodiments, the weight of each hypoglycemic Chinese medicinal honeyed pill is 5-8 g, preferably 6g.
The preparation method of the traditional Chinese medicine honeyed pill for reducing blood sugar provided by the application is simple to operate, does not need extra special equipment, and is suitable for industrial production. Meanwhile, the preparation method of the traditional Chinese medicine honeyed pill for reducing blood sugar is realized based on the traditional Chinese medicine composition for reducing blood sugar in any one of the first aspect, so that the traditional Chinese medicine honeyed pill for reducing blood sugar has at least all the beneficial effects brought by the technical scheme of the embodiment and is not repeated here. The operation steps involved in the preparation method of the traditional Chinese medicine honeyed pill for reducing blood sugar provided by the embodiment of the application can be carried out in a conventional manner in the art without special limitation or explanation, and are not repeated here.
The application will be further illustrated with reference to specific examples. It is to be understood that these examples are illustrative of the present application and are not intended to limit the scope of the present application. The experimental procedures, which are not specified in the following examples, are generally determined according to national standards. If the corresponding national standard does not exist, the method is carried out according to the general international standard, the conventional condition or the condition recommended by the manufacturer.
Example 1
The example provides a traditional Chinese medicine composition for reducing blood sugar, which comprises the following components in parts by weight (1 g in each 1 part by weight): 40 parts of tortoise plastron, 40 parts of medlar, 30 parts of aspongopus, 15 parts of semen astragali complanati, 5 parts of mulberry, 5 parts of ginseng, 5 parts of hawthorn and 5 parts of corn silk.
The preparation method of the traditional Chinese medicine composition for reducing blood sugar comprises the following steps:
grinding 40g of tortoise plastron, sieving with a 50-100 mesh sieve, adding 100mL of ethylenediamine tetraacetic acid with the concentration of 0.7mol/L, stirring for 2 hours, adding excessive sodium hydroxide with the concentration of 1mol/L, continuously stirring for 7 hours, centrifuging, filtering, and washing to obtain a tortoise plastron solid after decalcification treatment; adding the decalcified tortoise plastron solid into 200mL of water, steaming and boiling for 2 hours, cooling to room temperature, and adding trypsin with the enzyme amount of 2.5 ten thousand U to carry out enzymolysis for 7 hours to obtain the tortoise plastron protein extract;
grinding 30g of aspongopus, sieving with a 80-mesh sieve, adding into a supercritical device, performing supercritical extraction, placing the extracted product in an environment of 5 ℃ for 2 hours at constant temperature, centrifuging at 6000r/min for 20 minutes to remove bottom sediment, and vacuumizing the supernatant in a vacuum box at 45 ℃ for 12 hours to obtain aspongopus extract; wherein, the working parameters of the supercritical extraction comprise: the solvent is supercritical carbon dioxide fluid, the pressure is 45Mpa, the temperature is 50 ℃, the time is 1.5 hours, and CO 2 The flow rate of the fluid is 15kg/h;
pulverizing 40g of medlar, 30g of Murraya paniculata, 15g of semen astragali Complanati, 5g of mulberry, 5g of ginseng, 5g of hawthorn and 5g of corn silk, adding water with the weight being 7 times of the total weight of the traditional Chinese medicine raw materials in a water extraction mode for extraction, and concentrating under reduced pressure and drying to constant weight to obtain the mixed extract; wherein the extracted working parameters include: the temperature is 105 ℃, the time is 2 hours, and the times are 1 time;
mixing the tortoise plastron protein extract, the aspongopus extract and the mixed extract, and sieving the mixture with a 50-100-mesh sieve to obtain the traditional Chinese medicine composition for reducing blood sugar.
Example 2
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 1 only in that: the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight (1 g in each 1 part by weight): 60 parts of tortoise plastron, 60 parts of medlar, 40 parts of aspongopus, 25 parts of semen astragali complanati, 15 parts of mulberry, 15 parts of ginseng, 20 parts of hawthorn and 20 parts of corn silk; the rest steps and parameters are the same.
Example 3
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 1 only in that: the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight (1 g in each 1 part by weight): 45 parts of tortoise plastron, 45 parts of medlar, 35 parts of aspongopus, 20 parts of semen astragali complanati, 5 parts of mulberry, 5 parts of ginseng, 10 parts of hawthorn and 15 parts of corn silk; the rest steps and parameters are the same.
Example 4
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 1 only in that: the traditional Chinese medicine composition for reducing blood sugar comprises the following components in parts by weight (1 g in each 1 part by weight): 55 parts of tortoise plastron, 55 parts of medlar, 40 parts of aspongopus, 25 parts of semen astragali complanati, 10 parts of mulberry, 10 parts of ginseng, 20 parts of hawthorn and 20 parts of corn silk; the rest steps and parameters are the same.
Example 5
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 1 only in that: the traditional Chinese medicine composition comprises, by weight, 50 parts of tortoise plastron, 50 parts of medlar, 37 parts of aspongopus, 22 parts of aspongopus, 20 parts of semen astragali complanati, 10 parts of mulberry, 10 parts of ginseng, 20 parts of hawthorn and 18 parts of corn silk; the rest steps and parameters are the same.
Comparative example 1
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 5 only in that: the dosage of the aspongopus is adjusted to 20 parts; the rest steps and parameters are the same.
Comparative example 2
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 5 only in that: the dosage of the aspongopus is adjusted to 50 parts; the rest steps and parameters are the same.
Comparative example 3
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 5 only in that: the method for extracting the aspongopus by adopting the water extraction method comprises the following specific processes: grinding Aspongopus, sieving with a 50-100 mesh sieve, adding 7 times of water for extraction, concentrating under reduced pressure, and drying to constant weight to obtain Aspongopus extract; wherein the extracted working parameters include: the temperature is 105 ℃, the time is 2 hours, and the times are 1 time; the rest steps and parameters are the same.
Comparative example 4
The present example provides a hypoglycemic Chinese medicinal composition, which differs from example 5 only in that: extracting tortoise plastron by adopting a water extraction mode, wherein the specific process is as follows: grinding tortoise plastron, sieving with a 50-100 mesh sieve, adding water with the weight being 7 times of that of the tortoise plastron, extracting, concentrating under reduced pressure, and drying to constant weight to obtain the aspongopus extract; wherein the extracted working parameters include: the temperature is 105 ℃, the time is 2 hours, and the times are 1 time; the rest steps and parameters are the same.
Test case
This example demonstrates the efficacy of the hypoglycemic Chinese medicinal compositions provided in examples 1 to 5 and comparative examples 1 to 4.
The testing method and the grouping are as follows: 120 were used: SPF-class C57BL/6J male mice are randomly divided into 12 groups, namely a blank group (1 group; not molded), a model group (1 group; molded, not administered), a positive control group (1 group; molded, administered with commercial rosiglitazone sodium tablet at 5 mg/kg/day, and administered by intragastric administration), and a hypoglycemic Chinese medicinal composition group (9 group; molded, numbered 1 st to 11 hypoglycemic Chinese medicinal composition groups; 1 st to 5 th hypoglycemic Chinese medicinal composition groups are sequentially administered with hypoglycemic Chinese medicinal compositions provided in examples 1 to 5 respectively, and 6 th to 9 th hypoglycemic Chinese medicinal compositions are sequentially administered with hypoglycemic Chinese medicinal compositions provided in comparative examples 1 to 4 respectively, and the administration amounts are 50 mg/kg/day, and administered by intragastric administration). The positive control group and the hypoglycemic Chinese medicinal composition group are administered by gastric lavage for 1 time a day for 30 days continuously, and the blank blood sugar value and body weight of the mice are measured.
The molding method comprises the following steps: the mice are fasted for 24 hours (free drinking water), the molding is carried out by injecting the tetraoxypyrimidine into the abdominal cavity for 130mg/kg, and after the free diet for 7 days, the fasting blood glucose value is measured, and the blood glucose value is more than 10mmol/L, thus the molding is carried out successfully.
The test results are shown in Table 1.
TABLE 1
As can be seen from Table 1, the hypoglycemic effects of the hypoglycemic Chinese medicinal compositions provided in examples 1 to 5 are better than those of comparative examples 1 to 4, and the hypoglycemic effects of the hypoglycemic Chinese medicinal compositions provided in examples 1 to 5 provided in example 5 are optimal.
Application example
In the embodiment, the hypoglycemic Chinese medicinal composition provided in the embodiment 5 is prepared into honeyed pills and then applied to treating diabetics.
The preparation process of the traditional Chinese medicine honeyed pill comprises the following steps: weighing the traditional Chinese medicine composition for reducing blood sugar and honey according to the ratio of 1:1, heating and boiling the honey for 4-6 minutes, adding the honey into medicinal powder prepared by the traditional Chinese medicine composition, uniformly mixing, cooling and preparing into traditional Chinese medicine honeyed pills with the concentration of 6 g/granule.
Diabetes patient information: men, 41 years old, were diagnosed with type ii diabetes. Before treatment, the fasting blood glucose detection value is 19.53mmol/L, and the hypoglycemic traditional Chinese medicine composition provided in the example 5 is taken to prepare honeyed pills, each time in the morning and evening, 5 pills are taken for 1 month, and the fasting blood glucose detection value is 5.08mmol/L, so that the normal standard is restored.
In summary, the embodiment of the application provides a traditional Chinese medicine composition for reducing blood sugar, in particular to a traditional Chinese medicine composition for reducing blood sugar containing aspongopus, which has obvious blood sugar reducing effect due to mutual cooperation and combined action of all the components, can effectively treat and/or prevent diabetes, provides a new path for treatment of diabetics, and has practical application value.
The foregoing is only a specific embodiment of the application to enable those skilled in the art to understand or practice the application. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the application. Thus, the present application is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (10)
1. The traditional Chinese medicine composition for reducing blood sugar is characterized by comprising the following components in parts by weight:
40-60 parts of tortoise plastron, 40-60 parts of medlar, 30-40 parts of aspongopus, 15-25 parts of semen astragali complanati, 5-15 parts of mulberry, 5-15 parts of ginseng, 5-20 parts of hawthorn and 5-20 parts of corn silk.
2. The hypoglycemic traditional Chinese medicine composition according to claim 1, wherein the hypoglycemic traditional Chinese medicine composition comprises the following components in parts by weight:
45-55 parts of tortoise plastron, 45-55 parts of medlar, 35-40 parts of aspongopus, 20-25 parts of semen astragali complanati, 5-10 parts of mulberry, 5-10 parts of ginseng, 10-20 parts of hawthorn and 15-20 parts of corn silk.
3. The hypoglycemic traditional Chinese medicine composition according to claim 1, wherein the hypoglycemic traditional Chinese medicine composition comprises the following components in parts by weight:
50 parts of tortoise plastron, 50 parts of medlar, 37 parts of aspongopus, 22 parts of aspongopus, 20 parts of semen astragali complanati, 10 parts of mulberry, 10 parts of ginseng, 20 parts of hawthorn and 18 parts of corn silk.
4. Use of a hypoglycemic Chinese medicinal composition according to any one of claims 1-3 in the preparation of a hypoglycemic product.
5. The traditional Chinese medicine honeyed pill for reducing blood sugar is characterized in that the functional components of the traditional Chinese medicine honeyed pill for reducing blood sugar comprise the traditional Chinese medicine composition for reducing blood sugar according to any one of claims 1-3.
6. The hypoglycemic traditional Chinese medicine honeyed pill according to claim 5, wherein the preparation method of the hypoglycemic traditional Chinese medicine honeyed pill comprises the following steps:
decalcification treatment is carried out on tortoise plastron, and enzymolysis is carried out to obtain tortoise plastron protein extract;
carrying out supercritical extraction on the aspongopus to obtain aspongopus extract;
extracting fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis with water to obtain mixed extract;
mixing and sieving the tortoise plastron protein extract, the aspongopus extract and the mixed extract, adding the mixture into honey, stirring, and preparing the traditional Chinese medicine honeyed pill for reducing blood sugar.
7. The hypoglycemic Chinese medicinal honeyed pill according to claim 6, wherein the step of performing decalcification treatment and enzymolysis on tortoise plastron to obtain tortoise plastron protein extract comprises the following steps of:
crushing tortoise plastron, adding the crushed tortoise plastron into 0.5-1.0 mol/L ethylenediamine tetraacetic acid, and stirring for 1-3 hours to obtain a first reaction feed liquid;
adding 0.8-1.2 mol/L alkali liquor into the first reaction feed liquor, stirring for 4-7 hours, and then centrifugally filtering and washing to obtain decalcified tortoise plastron solids;
adding the decalcified tortoise plastron solid into water for cooking for 1-3 hours, cooling to room temperature, and adding trypsin with the enzyme amount of 2-3 ten thousand U for enzymolysis for 5-8 hours to obtain the tortoise plastron protein extract.
8. The hypoglycemic Chinese medicinal honeyed pill according to claim 6, wherein the working parameters of supercritical extraction comprise: the solvent is supercritical carbon dioxide fluid, the pressure is 40-50 Mpa, the temperature is 45-55 ℃ and the time is 1-2 hours.
9. The hypoglycemic Chinese medicinal honeyed pill according to claim 6, wherein the step of extracting wolfberry fruit, murraya paniculata, semen astragali complanati, mulberry, ginseng, hawthorn and corn silk with water to obtain a mixed extract comprises:
pulverizing fructus Lycii, herba Aspongopus, semen astragali Complanati, mori fructus, ginseng radix, fructus crataegi and stigma Maydis, extracting with 5-8 times of water, concentrating under reduced pressure, and drying to obtain the mixed extract; wherein the extracted working parameters include: the temperature is 100-110 ℃, the time is 1-3 hours, and the times are 1-3 times.
10. The hypoglycemic Chinese medicinal honeyed pill according to claim 6, wherein the weight ratio of the hypoglycemic Chinese medicinal composition to the honey is 1 (1-2).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310933673.1A CN116870102A (en) | 2023-07-27 | 2023-07-27 | Traditional Chinese medicine composition for reducing blood sugar and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310933673.1A CN116870102A (en) | 2023-07-27 | 2023-07-27 | Traditional Chinese medicine composition for reducing blood sugar and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116870102A true CN116870102A (en) | 2023-10-13 |
Family
ID=88266187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310933673.1A Pending CN116870102A (en) | 2023-07-27 | 2023-07-27 | Traditional Chinese medicine composition for reducing blood sugar and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116870102A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299663A (en) * | 2000-12-26 | 2001-06-20 | 朱保霖 | Diabetes treating medicine |
| CN105861608A (en) * | 2016-05-30 | 2016-08-17 | 深圳凯联龟业有限公司 | Method for preparing tortoise protein polypeptides |
| CN105878574A (en) * | 2016-06-23 | 2016-08-24 | 广州诺金制药有限公司 | Traditional Chinese medicine composition for treating kidney deficiency and preparation method thereof |
| CN106511394A (en) * | 2016-11-08 | 2017-03-22 | 山西中医学院 | Novel application of fatty oil extract of aspongopus |
| CN111000947A (en) * | 2019-12-30 | 2020-04-14 | 云南中科本草科技有限公司 | Composition for reducing blood sugar and body fat and preparation method and application thereof |
| CN112426488A (en) * | 2020-12-03 | 2021-03-02 | 遵义医科大学 | Traditional Chinese medicine composition for reducing blood sugar and preparation method and application thereof |
-
2023
- 2023-07-27 CN CN202310933673.1A patent/CN116870102A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299663A (en) * | 2000-12-26 | 2001-06-20 | 朱保霖 | Diabetes treating medicine |
| CN105861608A (en) * | 2016-05-30 | 2016-08-17 | 深圳凯联龟业有限公司 | Method for preparing tortoise protein polypeptides |
| CN105878574A (en) * | 2016-06-23 | 2016-08-24 | 广州诺金制药有限公司 | Traditional Chinese medicine composition for treating kidney deficiency and preparation method thereof |
| CN106511394A (en) * | 2016-11-08 | 2017-03-22 | 山西中医学院 | Novel application of fatty oil extract of aspongopus |
| CN111000947A (en) * | 2019-12-30 | 2020-04-14 | 云南中科本草科技有限公司 | Composition for reducing blood sugar and body fat and preparation method and application thereof |
| CN112426488A (en) * | 2020-12-03 | 2021-03-02 | 遵义医科大学 | Traditional Chinese medicine composition for reducing blood sugar and preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 李会芳;许剑侠;杜俊明;: "正交设计优化九香虫脂肪油超临界CO_2萃取工艺", 山西中医学院学报, no. 02, 28 April 2015 (2015-04-28), pages 30 - 32 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105638910B (en) | preparation method and application of blood sugar-reducing high-dietary-fiber soybean milk powder | |
| CN104126790A (en) | Phlegm-dampness constitution health food and preparation method thereof | |
| CN104288501A (en) | Blood glucose reducing particle and preparation method thereof | |
| CN102885931B (en) | Traditional Chinese medicine composition for treating abnormal menstruation | |
| CN107412721B (en) | Blood sugar-reducing bitter gourd polypeptide compound capsule and preparation method thereof | |
| CN1327887C (en) | Prepared Chinese medicine for treating fastidium of wean caused by deficient spleen and food stasis | |
| CN111840363B (en) | Natto-assisted hypoglycemic health-care composition and preparation method and application thereof | |
| CN102271698A (en) | Pharmaceutical composition and use for preparing medicament thereof | |
| CN104689006A (en) | Medicine for treating diabetes and preparation method of medicine | |
| CN101011562B (en) | Novel formulation of shenqiwendan decoction and production method thereof | |
| CN106492084A (en) | A kind of pure draft traditional Chinese medicine capable of reducing weight product and preparation method thereof | |
| CN107998240A (en) | A kind of formula for the fatigue-relieving clearing health care buccal tablets that refresh the mind and preparation method thereof | |
| CN116870102A (en) | Traditional Chinese medicine composition for reducing blood sugar and application thereof | |
| CN114209758A (en) | Traditional Chinese medicine compound composition capable of maintaining blood sugar health level and preparation method and application thereof | |
| CN113785948A (en) | Solid beverage capable of benefiting qi, promoting production of body fluid and relaxing bowel and preparation method thereof | |
| CN1070827A (en) | Up-to-date therapeutic agent of diabetes and method for making thereof | |
| CN108686094B (en) | Traditional Chinese medicine for reducing blood sugar and preparation method thereof | |
| CN115120684A (en) | Traditional Chinese medicine formula for treating diabetes and processing method thereof | |
| CN106177416B (en) | A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof | |
| CN101371875A (en) | Method for extracting and preparing total saponin of compound abnormal savda mature agent | |
| CN114848748B (en) | Composition with blood sugar reducing effect and preparation method thereof | |
| CN114732876B (en) | Traditional Chinese medicine composition for treating type II diabetes | |
| CN105055911A (en) | Chinese and western medicine composition for treating diabetes and preparation method thereof | |
| CN113616732A (en) | Formula and preparation method of ginseng-olive tablet | |
| CN114344429A (en) | Herbal atomized composition for promoting digestion and invigorating stomach and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |